#docs
Latest news and interesting information about docs.
Dr. Martens Q2 2026: revenue dip, stock surges
Dr. Martens Q2 2026 earnings: stock surges 8.41% despite revenue dip. Consumer-first strategy drives profit growth. Undervalued according to Bond.az analysis.
Amdocs Stock: AI Shift and Telecom Pressures
SWOT analysis of Amdocs (DOX) stock: AI transition, telecom pressures, financials, and future outlook.
Uri Geller Comments on Declassified UFO Docs
Famous illusionist Uri Geller comments on declassified UFO documents from the U.S. Department of Defense, calling it humanity's awakening.
Needham Cuts Doximity PT on Growth Worries
Needham lowers Doximity price target from $55 to $27 but keeps Buy rating. Stock down 61% in past year. AI investments and analyst downgrades discussed.
...



